Is Cross Country Healthcare still publicly traded?

No. Cross Country Healthcare (Nasdaq: CCRN) was taken private by Knox Lane LP for $13.25/share (~$437-440 million) in a deal that closed July 21, 2026, ending its Nasdaq listing.

Is Cross Country Healthcare profitable?

No. It posted a $94.9 million net loss for full-year 2025 (largely Q4 impairment charges from the failed Aya merger) and a smaller $4.3 million net loss in Q1 2026, on revenue down 22% and 18% year-over-year respectively.

Who owns Cross Country Healthcare now?

Private equity firm Knox Lane LP acquired Cross Country Healthcare for $13.25/share, closing July 21, 2026. Joel Tremblay, formerly president/COO of rival Medical Solutions, was installed as CEO.

Did Aya Healthcare buy Cross Country Healthcare?

No. Aya Healthcare agreed in December 2024 to acquire Cross Country for ~$18.61/share (~$615 million), but terminated the deal on December 4, 2025 after FTC antitrust concerns, paying Cross Country a $20 million termination fee.

Who is Cross Country Healthcare's biggest competitor?

Aya Healthcare and AMN Healthcare are Cross Country's largest rivals; Cross Country ranked 7th among US healthcare staffing firms per Staffing Industry Analysts as of December 2025, well behind both larger, more consolidated competitors.

Could AI replace Cross Country Healthcare's staffing business?

Core clinician placement (licensure, credentialing, liability) resists AI substitution, but Cross Country has already cut corporate headcount 21% and shifted 700-800 roles to a Pune, India center via automation, per its March 2026 earnings call.

Job boards and HR platforms · subsidiary of Knox Lane LP · United States

Cross Country Healthcare

crosscountry.com ↗

Staffing firm placing travel nurses and clinicians for hospitals, now private.

Losing its protection

Assessed 22 July 2026 · Evidence as of 22 July 2026

The structural protection is eroding.

On the recordSince 22 July 2026 · Checkable from Q4 2026 · Every call on the record Checkpoint: Q3/Q4 2026 earnings test guided return to revenue growth

The call

Cross Country Healthcare goes private at a price 30% below Aya's failed bid, cutting staff and offshoring work as revenue keeps falling.

Cross Country Healthcare finds temporary nurses and doctors for hospitals and clinics. It is getting harder to compete because larger rivals like Aya and AMN have more money, better technology, and bigger client lists. The company's own revenue dropped 22 percent last year, and it was bought by a private investor at a steep discount, suggesting its business got weaker. While hospitals will always need real people on staff (not just robots), that does not help Cross Country stand out. The company could turn things around if its education staffing business starts growing again in the second half of 2026, or if the new owner and CEO Joel Tremblay can cut costs fast enough to compete.

Why

AI pressure: Aya Healthcare and AMN Healthcare's AI-driven VMS platforms. AI-driven VMS tools from Aya and AMN cut sourcing and credentialing costs; Cross Country answers with layoffs and offshoring to Pune. Could AI do the core job? Only partly.

Bigger players: Aya Healthcare and AMN Healthcare. Aya and AMN, larger and consolidating, pull hospital MSP contracts and travel nurse volume as Cross Country's revenue falls 22%. Could a giant copy it? Yes, easily.

What protects it. Hospital credentialing rules and existing MSP contracts slow switching, but that protects the whole staffing industry, not Cross Country alone.

What would change this call

Cross Country reports Q3/Q4 2026 revenue flat or still declining YoY versus guided recovery. Would show the revenue slide continues despite PE-backed restructuring.
News of major hospital MSP or VMS contracts moving from Cross Country to Aya or AMN. Would show direct customer loss to larger, better-capitalized rivals.
Further headcount cuts or facility closures announced under Knox Lane ownership within the year. Would show continued cost distress rather than stabilization.

Key numbers

FY2025 revenue $1.05B, down 22% YoY (2025-12-31)
Q1 2026 revenue $241.1M, down 18% YoY (2026-03-31)
Knox Lane bought firm at $13.25/share, deal closed (2026-07-21)

Named risks

Revenue declined 22% in FY2025 and 18% YoY in Q1 2026 amid market normalization. Severity: high
Loss of public disclosure and financial transparency after going private July 21, 2026. Severity: medium
Integration and restructuring risk under new PE owner Knox Lane and new CEO. Severity: medium
Locums division carve-out to All Star Healthcare may signal further fragmentation. Severity: medium
Back-office roles already offshored/automated to Pune, India, cutting headcount 21%. Severity: medium

Rivals, as read in July 2026

Rival	Direction	Evidence
Aya Healthcare	losing to	Ranked above Cross Country per SIA; its own LotusOne AI-VMS launched July 2024, and it walked away from acquiring CCRN Dec 2025
AMN Healthcare	losing to	Larger scale; claims 35% hiring-time cut via 2024 AI cloud platform (AMN-claimed, per third-party report)
Medical Solutions	contesting	Cross Country recruited its ex-president/COO Joel Tremblay as new CEO after July 2026 buyout

Questions people ask

Is Cross Country Healthcare still publicly traded?: No. Cross Country Healthcare (Nasdaq: CCRN) was taken private by Knox Lane LP for $13.25/share (~$437-440 million) in a deal that closed July 21, 2026, ending its Nasdaq listing.
Is Cross Country Healthcare profitable?: No. It posted a $94.9 million net loss for full-year 2025 (largely Q4 impairment charges from the failed Aya merger) and a smaller $4.3 million net loss in Q1 2026, on revenue down 22% and 18% year-over-year respectively.
Who owns Cross Country Healthcare now?: Private equity firm Knox Lane LP acquired Cross Country Healthcare for $13.25/share, closing July 21, 2026. Joel Tremblay, formerly president/COO of rival Medical Solutions, was installed as CEO.
Did Aya Healthcare buy Cross Country Healthcare?: No. Aya Healthcare agreed in December 2024 to acquire Cross Country for ~$18.61/share (~$615 million), but terminated the deal on December 4, 2025 after FTC antitrust concerns, paying Cross Country a $20 million termination fee.
Who is Cross Country Healthcare's biggest competitor?: Aya Healthcare and AMN Healthcare are Cross Country's largest rivals; Cross Country ranked 7th among US healthcare staffing firms per Staffing Industry Analysts as of December 2025, well behind both larger, more consolidated competitors.
Could AI replace Cross Country Healthcare's staffing business?: Core clinician placement (licensure, credentialing, liability) resists AI substitution, but Cross Country has already cut corporate headcount 21% and shifted 700-800 roles to a Pune, India center via automation, per its March 2026 earnings call.

Timeline

2026-07-21Knox Lane closes acquisition at $13.25/share; Joel Tremblay named CEO; locums unit sold to All Star Healthcare
2026-05-14Announces exclusive 36-month Optime workforce forecasting partnership embedded in Intellify platform
2026-05-07Reports Q1 2026 revenue of $241.1M, down 18% YoY, net loss $4.3M
2026-05-06Agrees to be acquired by Knox Lane LP for $13.25/share, ~$437-440M
2026-03-04Reports FY2025 revenue $1.05B (-22% YoY) and $94.9M net loss
2025-12-04Aya Healthcare terminates $615M merger agreement; pays $20M termination fee
2025-12Kevin Clark returns as CEO; company authorizes $40M share buyback
2024-12Aya Healthcare agrees to acquire Cross Country for $18.61/share (~$615M)

Revision history

22 July 2026

First assessed. Losing its protection. The text above is fixed as of this date and is not edited afterwards.

In the same band

Deel Beisen Holdings Saramin HR